Pancreatic Cancer Trial, Recruiting (NCT03747588)

Pancreatic Cancer Trial, Recruiting NCT03747588 Sponsor: Peking Union Medical College Hospital Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03747588 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged between 18 and 75 years old
People who have been diagnosed with pancreatic cancer, bile duct cancer, or cancer of the ampulla (a small opening where the bile and pancreatic ducts meet the small intestine), and who have had a surgical procedure called a pancreatoduodenectomy (an operation to remove part of the pancreas and surrounding structures)
People whose scans before surgery showed that the cancer could be fully removed or was on the borderline of being removable

Who may not be able to join:

People whose tumour in the head of the pancreas was found to be non-cancerous (benign)
People whose CT scan showed that a major blood vessel near the pancreas (called the superior mesenteric vein) was surrounded by the tumour by more than halfway around, or whose cancer had spread to other parts of the body
People whose planned keyhole (minimally invasive) surgery had to be changed to open surgery during the operation due to complications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +861069152600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03747588

Sponsor: Peking Union Medical College Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +861069152600

More information: https://clinicaltrials.gov/study/NCT03747588

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged between 18 and 75 years old
People who have been diagnosed with pancreatic cancer, bile duct cancer, or cancer of the ampulla (a small opening where the bile and pancreatic ducts meet the small intestine), and who have had a surgical procedure called a pancreatoduodenectomy (an operation to remove part of the pancreas and surrounding structures)
People whose scans before surgery showed that the cancer could be fully removed or was on the borderline of being removable

Who may not be able to join:

People whose tumour in the head of the pancreas was found to be non-cancerous (benign)
People whose CT scan showed that a major blood vessel near the pancreas (called the superior mesenteric vein) was surrounded by the tumour by more than halfway around, or whose cancer had spread to other parts of the body
People whose planned keyhole (minimally invasive) surgery had to be changed to open surgery during the operation due to complications

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking Union Medical College Hospital

Registry

ClinicalTrials.gov

Start date

1 December 2018

Est. completion

1 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall complications; Pancreatic fistula; Intra-abdominal bleeding; Intra-abdominal infection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov